Fungal peptides from pneumonitis hypersensitivity etiologic agents are able to induce specific cellular immune response

Affiliation auteurs!!!! Error affiliation !!!!
TitreFungal peptides from pneumonitis hypersensitivity etiologic agents are able to induce specific cellular immune response
Type de publicationJournal Article
Year of Publication2017
AuteursBellanger A-P, Lignon T, Godet Y, Rognon B, Reboux G, Gbaguidi-Haore H, Borg C, Millon L
JournalJOURNAL OF IMMUNOLOGICAL METHODS
Volume440
Pagination67-73
Date PublishedJAN
Type of ArticleArticle
ISSN0022-1759
Mots-clésELISPOT assay, Epitopes, Hypersensitivity pneumonitis, IFN gamma, T cell
Résumé

Purpose: Hypersensitivity pneumonitis (HP) is an immunoallergic disease due to chronic exposure to high quantities of different microorganisms such as Mycobacterium immunogenum (Mi), a mycobacterium, and Lichtheimia corymbifera (Lc), a filamentous fungus. It has recently been demonstrated that the protein DLDH (dihydrolipoyl dehydrogenase), is common to these microorganisms. This study aimed to investigate the immune potential of overlapping peptide pools covering the MiDLDH and LcDLDH. Experimental design: A selection of 34 peptides, from the MiDLDH and LcDLDH, able to interact with Major Histocompatibility Complex (MHC) 1 and MHC 2, was obtained using three different epitope prediction websites. By means of ELISPOT assays, we compared the frequency of Interferon gamma (IFN gamma) secreting peripheral blood mononuclear cells (PBMC) after stimulation with overlapping peptide pools. Tests were performed using cells from 35 healthy blood donors. Results: One peptide pool containing five peptides from MiDLDH and able to interact with MHC 2 induced a marked IFN gamma specific immune response (Pool F, p < 0.001, Wilcoxon signed-rank test). Conclusion: This study demonstrated that peptides from microorganisms involved in HP were able to induce a high IFN gamma specific immune response after stimulation of PBMCs from healthy blood donors which could be useful to develop an effective prevention strategy. (C) 2016 Elsevier B.V. All rights reserved.

DOI10.1016/j.jim.2016.11.009